JAZZ Competition Analysis

Jazz Pharmaceuticals plc Peer Comparison

Metric	Value	Ranking
Market Cap	$8.2 Billion	10/23	SGEN $43.2B	ARGX $35.8B	ALNY $34.3B	UTHR $15.8B	INCY $13.3B	BMRN $12.6B	TECH $10.8B	PCVX $10.6B	EXEL $9.4B	JAZZ $8.2B	ASND $7.5B	HALO $7.4B	LEGN $6.6B	BPMC $6.6B	RARE $4.0B	APLS $3.5B	DNLI $3.0B	DICE $2.3B	PTGX $2.2B	VRDN $1.4B	LQDA $1.4B	LRMR $206.1M	INBX $185.7M
Gross Margin	100%	1/23	JAZZ 100%	PTGX 100%	VRDN 100%	ALNY 99%	BPMC 98%	EXEL 96%	INCY 92%	UTHR 89%	ARGX 89%	RARE 85%	HALO 83%	APLS 81%	ASND 81%	SGEN 75%	BMRN 74%	TECH 65%	LQDA 65%	LEGN 65%	DNLI 0%	LRMR 0%	PCVX 0%	INBX 0%	DICE 0%
Profit Margin	20%	4/23	HALO 47%	UTHR 41%	EXEL 25%	JAZZ 20%	BMRN 14%	TECH 12%	INCY 9%	DNLI 0%	LQDA 0%	LRMR 0%	PCVX 0%	INBX 0%	DICE 0%	ARGX -4%	ALNY -27%	SGEN -33%	APLS -33%	BPMC -44%	LEGN -78%	RARE -96%	PTGX -100%	ASND -100%	VRDN -100%
EBITDA margin	25%	4/23	HALO 56%	UTHR 56%	EXEL 28%	JAZZ 25%	TECH 24%	BMRN 16%	INCY 16%	ARGX -17%	ALNY -18%	BPMC -26%	SGEN -34%	APLS -38%	LEGN -69%	RARE -95%	DNLI -100%	LRMR -100%	PCVX -100%	INBX -100%	DICE -100%	ASND -123%	LQDA -656%	PTGX -887%	VRDN -97070%
Quarterly Revenue	$1.1 Billion	3/23	BMRN $733.9B	INCY $1.1B	JAZZ $1.1B	ARGX $877.3M	UTHR $748.9M	SGEN $648.7M	EXEL $478.1M	ALNY $420.1M	TECH $297.0M	HALO $290.1M	APLS $176.6M	LEGN $160.2M	RARE $139.5M	BPMC $128.2M	ASND $63.6M	PTGX $4.7M	LQDA $4.4M	VRDN $86,000	DNLI $0	LRMR $0	PCVX $0	INBX $0	DICE $0
Quarterly Earnings	$215.1 Million	3/23	BMRN $106.1B	UTHR $309.1M	JAZZ $215.1M	HALO $137.0M	EXEL $118.0M	INCY $106.5M	TECH $34.9M	LQDA -$0	LRMR -$15.5M	ARGX -$32.5M	PTGX -$33.2M	DICE -$34.8M	INBX -$43.9M	BPMC -$56.3M	APLS -$57.4M	VRDN -$76.7M	PCVX -$103.1M	DNLI -$107.2M	ASND -$109.0M	ALNY -$111.6M	LEGN -$125.3M	RARE -$133.5M	SGEN -$215.8M
Quarterly Free Cash Flow	$412.7 Million	2/23	BMRN $321.2B	JAZZ $412.7M	UTHR $300.7M	EXEL $296.1M	INCY $293.2M	HALO $113.9M	TECH $77.5M	ALNY $39.5M	APLS $34.1M	BPMC -$13.7M	PCVX -$21.7M	LRMR -$24.6M	LQDA -$26.8M	PTGX -$28.6M	DICE -$30.4M	INBX -$30.5M	RARE -$56.1M	DNLI -$63.0M	VRDN -$68.0M	LEGN -$77.9M	SGEN -$79.8M	ARGX -$98.3M	ASND -$0
Trailing 4 Quarters Revenue	$4.0 Billion	3/23	BMRN $1.4T	INCY $4.1B	JAZZ $4.0B	UTHR $2.8B	SGEN $2.3B	EXEL $2.0B	ARGX $2.0B	ALNY $2.0B	TECH $1.2B	HALO $947.4M	APLS $675.9M	RARE $522.7M	LEGN $520.2M	BPMC $434.4M	ASND $360.0M	PTGX $323.8M	LQDA $15.6M	INBX $1.7M	VRDN $302,000	DNLI $0	LRMR $0	PCVX $0	DICE $0
Trailing 4 Quarters Earnings	$463.2 Million	5/23	BMRN $733.9B	INCY $1.1B	JAZZ $1.1B	ARGX $877.3M	UTHR $748.9M	SGEN $648.7M	EXEL $478.1M	ALNY $420.1M	TECH $297.0M	HALO $290.1M	APLS $176.6M	LEGN $160.2M	RARE $139.5M	BPMC $128.2M	ASND $63.6M	PTGX $4.7M	LQDA $4.4M	VRDN $86,000	DNLI -$0	LRMR -$0	PCVX -$0	INBX -$0	DICE -$0
Quarterly Earnings Growth	46%	8/23	BMRN 262617%	EXEL 11233%	LQDA 100%	HALO 67%	ARGX 66%	APLS 59%	BPMC 58%	JAZZ 46%	ASND 39%	TECH 27%	RARE 16%	UTHR 16%	INBX 15%	PTGX 3%	DNLI -8%	PCVX -11%	SGEN -13%	INCY -38%	VRDN -61%	DICE -62%	LRMR -71%	LEGN -101%	ALNY -176%
Annual Earnings Growth	1%	12/23	INBX 951%	PTGX 214%	EXEL 91%	BPMC 76%	ALNY 51%	APLS 51%	LEGN 47%	HALO 28%	ASND 19%	RARE 13%	UTHR 6%	JAZZ 1%	TECH -12%	LQDA -12%	VRDN -21%	BMRN -25%	SGEN -26%	DICE -26%	ARGX -47%	PCVX -71%	LRMR -90%	INCY -96%	DNLI -195%
Quarterly Revenue Growth	9%	14/23	BMRN 126140%	ARGX 224%	BPMC 127%	APLS 78%	LEGN 67%	RARE 42%	HALO 34%	SGEN 27%	INCY 24%	UTHR 23%	LQDA 21%	ASND 20%	VRDN 19%	JAZZ 9%	TECH 9%	EXEL 1%	PTGX 0%	LRMR 0%	PCVX 0%	DICE 0%	ALNY -44%	DNLI -100%	INBX -100%
Annual Revenue Growth	4%	16/23	INBX 730%	ARGX 117%	BPMC 89%	APLS 76%	ASND 72%	LEGN 65%	RARE 24%	ALNY 18%	SGEN 15%	UTHR 15%	HALO 8%	INCY 8%	TECH 8%	EXEL 7%	VRDN 5%	JAZZ 4%	PTGX 0%	LRMR 0%	PCVX 0%	DICE 0%	LQDA -13%	BMRN -23%	DNLI -100%
Cash On Hand	$2.2 Billion	2/23	BMRN $675.4B	JAZZ $2.2B	UTHR $1.6B	ARGX $1.4B	INCY $1.3B	ALNY $1.1B	PCVX $1.1B	ASND $687.4M	LEGN $459.3M	SGEN $428.6M	APLS $396.9M	EXEL $258.3M	LQDA $204.4M	VRDN $200.3M	INBX $196.3M	TECH $177.5M	HALO $154.3M	RARE $150.6M	PTGX $131.1M	DNLI $90.6M	BPMC $89.4M	DICE $73.5M	LRMR $35.1M
Short Term Debt	$31.0 Million	5/23	ASND $494.2M	UTHR $400.0M	BPMC $45.0M	ALNY $42.1M	JAZZ $31.0M	BMRN $15.6M	RARE $10.4M	PCVX $9.6M	DNLI $8.0M	APLS $6.8M	ARGX $5.9M	LEGN $4.3M	INCY $3.9M	INBX $1.8M	DICE $1.5M	LQDA $1.2M	LRMR $1.0M	PTGX $45,000	HALO -$0	SGEN -$0	TECH -$0	VRDN -$0	EXEL -$3.3M
Long Term Debt	$6.2 Billion	2/23	BMRN $594.6B	JAZZ $6.2B	HALO $1.5B	ALNY $1.3B	RARE $829.7M	TECH $381.6M	ASND $372.5M	LEGN $342.2M	BPMC $341.5M	EXEL $194.4M	SGEN $113.5M	APLS $104.7M	DNLI $44.5M	INCY $28.2M	VRDN $20.5M	PCVX $18.3M	DICE $11.0M	PTGX $10.9M	LRMR $4.3M	LQDA $1.4M	UTHR $0	ARGX $0	INBX $0
PE	17.68	5/23	INCY 409.53	TECH 68.32	EXEL 20.06	HALO 18.84	JAZZ 17.68	UTHR 14.20	PTGX 13.05	INBX 0.11	BMRN 0.10	ALNY -1.00	DNLI -1.00	SGEN -1.00	RARE -1.00	BPMC -1.00	ARGX -1.00	APLS -1.00	ASND -1.00	LQDA -1.00	LRMR -1.00	LEGN -1.00	PCVX -1.00	VRDN -1.00	DICE -1.00
PS	2.05	18/23	VRDN 4684.57	INBX 107.11	LQDA 88.16	ASND 19.05	SGEN 18.76	ARGX 17.78	ALNY 17.03	BPMC 15.14	LEGN 12.65	TECH 9.03	HALO 7.80	RARE 7.67	PTGX 6.89	UTHR 5.72	APLS 5.25	EXEL 4.64	INCY 3.26	JAZZ 2.05	BMRN 0.01	DNLI -1.00	LRMR -1.00	PCVX -1.00	DICE -1.00
PB	1.96	19/23	ALNY 1060.26	BPMC 21.01	SGEN 16.92	HALO 16.33	APLS 14.96	LQDA 12.45	RARE 11.33	ARGX 8.41	LEGN 5.90	TECH 5.20	DICE 4.37	INCY 4.19	PTGX 4.19	EXEL 4.12	PCVX 3.12	UTHR 2.59	DNLI 2.27	VRDN 2.00	JAZZ 1.96	LRMR 1.04	INBX 1.04	BMRN 0.00	ASND 0.00
PC	3.69	21/23	SGEN 100.70	BPMC 73.62	TECH 60.85	HALO 47.91	EXEL 36.26	DNLI 33.06	ALNY 31.19	DICE 30.91	RARE 26.63	ARGX 24.92	PTGX 17.01	LEGN 14.33	ASND 10.97	INCY 10.20	UTHR 10.15	PCVX 10.14	APLS 8.94	VRDN 7.06	LQDA 6.73	LRMR 5.88	JAZZ 3.69	INBX 0.95	BMRN 0.02
Liabilities to Equity	1.94	6/23	ALNY 128.97	HALO 3.68	RARE 3.42	BPMC 2.83	APLS 2.80	JAZZ 1.94	LQDA 1.29	INCY 0.58	LEGN 0.56	SGEN 0.42	EXEL 0.30	TECH 0.28	BMRN 0.27	INBX 0.25	UTHR 0.17	PTGX 0.14	ARGX 0.13	DNLI 0.10	LRMR 0.10	VRDN 0.09	DICE 0.06	PCVX 0.04	ASND 0.00
ROA	0.04	7/23	INBX 738%	PTGX 28%	HALO 19%	EXEL 16%	UTHR 16%	TECH 6%	JAZZ 4%	BMRN 2%	INCY 1%	ARGX -6%	ALNY -8%	BPMC -11%	PCVX -14%	DICE -18%	LEGN -20%	SGEN -21%	APLS -28%	DNLI -29%	LRMR -30%	VRDN -33%	RARE -36%	LQDA -38%	ASND -43%
ROE	0.11	7/23	INBX 920%	ASND 482%	HALO 87%	PTGX 32%	EXEL 21%	UTHR 18%	JAZZ 11%	TECH 8%	BMRN 2%	INCY 1%	ARGX -6%	PCVX -15%	DICE -19%	SGEN -29%	LEGN -31%	DNLI -32%	LRMR -33%	VRDN -36%	BPMC -41%	LQDA -87%	APLS -105%	RARE -161%	ALNY -1027%
Current Ratio	1.52	17/23	PCVX 25.05	DICE 17.42	VRDN 11.99	DNLI 10.73	LRMR 10.62	ARGX 8.98	PTGX 8.39	UTHR 6.97	INBX 5.05	BMRN 4.77	TECH 4.51	EXEL 4.32	SGEN 3.35	LEGN 2.80	INCY 2.72	LQDA 1.78	JAZZ 1.52	APLS 1.36	BPMC 1.35	RARE 1.30	HALO 1.27	ALNY 1.01	ASND 0.92
Quick Ratio	0.27	23/23	INCY 409.53	TECH 68.32	EXEL 20.06	HALO 18.84	JAZZ 17.68	UTHR 14.20	PTGX 13.05	INBX 0.11	BMRN 0.10	ALNY -1.00	DNLI -1.00	SGEN -1.00	RARE -1.00	BPMC -1.00	ARGX -1.00	APLS -1.00	ASND -1.00	LQDA -1.00	LRMR -1.00	LEGN -1.00	PCVX -1.00	VRDN -1.00	DICE -1.00
Long Term Debt to Equity	1.47	4/23	ALNY} 38.93	HALO} 3.32	RARE} 2.39	JAZZ} 1.47	BPMC} 1.09	APLS} 0.44	LEGN} 0.31	TECH} 0.18	BMRN} 0.11	EXEL} 0.09	SGEN} 0.04	DNLI} 0.03	VRDN} 0.03	PTGX} 0.02	LRMR} 0.02	DICE} 0.02	INCY} 0.01	LQDA} 0.01	PCVX} 0.01	UTHR} 0.00	ARGX} 0.00	INBX} 0.00	ASND} -3.48
Debt to Equity	1.48	3/23	ALNY 40.24	HALO 3.32	JAZZ 1.48	BPMC 1.23	APLS 0.47	LEGN 0.31	TECH 0.19	BMRN 0.11	EXEL 0.09	UTHR 0.07	DNLI 0.04	SGEN 0.04	RARE 0.03	LRMR 0.03	VRDN 0.03	PTGX 0.02	LQDA 0.02	DICE 0.02	INCY 0.01	ARGX 0.01	PCVX 0.01	INBX 0.01	ASND -8.10
Burn Rate	57.21	1/23	JAZZ 57.21	ARGX 42.37	PCVX 9.88	ALNY 6.38	APLS 6.27	INBX 4.43	PTGX 3.90	LEGN 3.28	ASND 2.66	VRDN 2.58	LRMR 2.20	DICE 2.06	SGEN 1.95	BPMC 1.10	RARE 0.89	DNLI 0.82	LQDA -1.00	HALO -2.01	EXEL -2.33	UTHR -7.43	BMRN -8.21	TECH -9.05	INCY -12.50
Cash to Cap	0.27	3/23	BMRN 53.81	INBX 1.06	JAZZ 0.27	LRMR 0.17	LQDA 0.15	VRDN 0.14	APLS 0.11	INCY 0.10	UTHR 0.10	PCVX 0.10	ASND 0.09	LEGN 0.07	PTGX 0.06	RARE 0.04	ARGX 0.04	ALNY 0.03	EXEL 0.03	DNLI 0.03	DICE 0.03	HALO 0.02	TECH 0.02	SGEN 0.01	BPMC 0.01
CCR	1.92	6/23	BMRN 3.03	ARGX 3.03	INCY 2.75	EXEL 2.51	TECH 2.22	JAZZ 1.92	LRMR 1.59	UTHR 0.97	VRDN 0.89	DICE 0.87	PTGX 0.86	HALO 0.83	INBX 0.70	LEGN 0.62	DNLI 0.59	RARE 0.42	SGEN 0.37	BPMC 0.24	PCVX 0.21	ALNY -0.35	APLS -0.59	LQDA -1.00	ASND
EV to EBITDA	46.70	5/23	TECH} 152.84	EXEL} 68.37	INCY} 66.90	HALO} 53.57	JAZZ} 46.70	UTHR} 34.99	INBX} 0.19	BMRN} -0.60	DNLI} -1.00	LRMR} -1.00	PCVX} -1.00	DICE} -1.00	VRDN} -14.79	RARE} -29.32	LQDA} -40.24	APLS} -48.28	PTGX} -50.90	LEGN} -58.85	ASND} -118.75	SGEN} -191.83	BPMC} -206.03	ARGX} -229.54	ALNY} -448.68
EV to Revenue	3.04	16/23	VRDN 4089.22	LQDA 75.24	ASND 23.46	SGEN 18.62	ALNY 17.13	ARGX 17.08	BPMC 15.83	LEGN 12.43	HALO 9.23	TECH 9.22	RARE 7.40	PTGX 6.52	UTHR 5.30	APLS 4.82	EXEL 4.61	JAZZ 3.04	INCY 2.95	BMRN -0.05	DNLI -1.00	LRMR -1.00	PCVX -1.00	DICE -1.00	INBX -5.06

Jazz Pharmaceuticals plc Peer Comparison

Cookies